Biosimilars – Commercial Best Practices In The Age Of Sustainability
Executive Summary
The commercial landscape for biosimilars is constantly evolving. More emphasis is now being placed on sustainability than winning at all costs and any price. And with this comes a need for biosimilar companies to adopt commercial strategies that are flexible, agile and future-focused.